Resilience
Overview
Resilience is a pharmaceutical company headquartered in Blue Ash, United States, founded in 2020, with 1,001-5,000 employees.
FDA compliance signals
15 FDA enforcement records linked to this company.
- 4832025-01-21
SOPs not followed / documented
- 4832025-01-21
Investigations of discrepancies, failures
- 4832025-01-21
Procedures for sterile drug products
- 4832025-01-21
Identification of Person Performing Review of Lab Records
- 4832025-01-21
Microbiological Contamination Exam
- 4832025-01-21
Complete test data included in records
- 4832018-03-08
Control procedures to monitor and validate performance
- 4832018-03-08
Procedures not in writing, fully followed
- 4832014-09-25
Contamination, chemical or physical change, deterioration
- 4832014-07-22
Mix-up
- 4832014-07-22
Procedures for sterile drug products
- 4832014-07-22
Following/documenting laboratory controls
- 4832014-07-22
SOPs not followed / documented
- 4832014-07-22
Written procedures not established/followed
- warning_letter2009-02-27
FDA Warning Letter (drug product)
Is this Resilience? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.